We are live on
!
Find out more
Natixis Advisors Portfolio holdings
AUM
$71.9B
1-Year Est. Return
28.03%
This Fund
S&P 500
This Quarter
Est. Return
+4.94%
1 Year Est. Return
+28.03%
3 Year Est. Return
+95.12%
5 Year Est. Return
+131.42%
10 Year Est. Return
+475.22%
AUM
$12.2B
AUM Growth
+$822M
(+7.2%)
Cap. Flow
+$335M
Cap. Flow
% of AUM
2.73%
Top 10 Holdings %
Top 10 Hldgs %
14.79%
Holding
1,100
New
46
Increased
577
Reduced
433
Closed
42
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$28.9M |
| 2 |
Vanguard Value ETF
VTV
|
+$19.9M |
| 3 |
Virtu Financial
VIRT
|
+$18M |
| 4 |
Alcon
ALC
|
+$18M |
| 5 |
Procter & Gamble
PG
|
+$13M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ecolab
ECL
|
+$22.6M |
| 2 |
Clorox
CLX
|
+$15.2M |
| 3 |
Rithm Capital
RITM
|
+$9.88M |
| 4 |
APC
Anadarko Petroleum
APC
|
+$8.85M |
| 5 |
State Street
STT
|
+$8.55M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.6% |
| 2 | Financials | 15.41% |
| 3 | Healthcare | 12.01% |
| 4 | Consumer Discretionary | 9.48% |
| 5 | Industrials | 9.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
CVS Health
CVS
$137B
| $19.3M | 0.16% |
354,636
+130,714
| +58% | +$7.04M |
|
152
Stryker
SYK
$127B
| $19.2M | 0.16% |
93,285
+3,438
| +4% | +$657K |
|
|
153
Alcon
ALC
$33.1B
| $19M | 0.16% |
+306,725
| New | +$18M |
|
154
MetLife
MET
$61B
| $18.6M | 0.15% |
375,207
+49,693
| +15% | +$2.34M |
|
155
Duke Energy
DUK
$102B
| $18.5M | 0.15% |
209,865
-12,626
| -6% | -$1.12M |
|
156
Brink's
BCO
$5.02B
| $18.4M | 0.15% |
227,244
+1,086
| +0.5% | +$86.5K |
|
157
Citizens Financial Group
CFG
$30.4B
| $18.4M | 0.15% |
520,776
+43,196
| +9% | +$1.51M |
|
158
McDonald's
MCD
$188B
| $18.1M | 0.15% |
87,368
+7,796
| +10% | +$1.54M |
|
|
FISV
159
Fiserv Inc
FISV
$27.2B
| $18.1M | 0.15% |
198,298
+3,288
| +2% | +$288K |
|
160
FirstEnergy
FE
$28.9B
| $17.9M | 0.15% |
418,939
+29,933
| +8% | +$1.26M |
|
|
ANSS
161
DELISTED
Ansys
ANSS
| $17.8M | 0.15% |
86,974
+2,387
| +3% | +$455K |
|
162
HSBC
HSBC
$355B
| $17.5M | 0.14% |
419,151
+25,911
| +7% | +$1.09M |
|
163
Trane Technologies
TT
$106B
| $17.4M | 0.14% |
137,070
+3,705
| +3% | +$443K |
|
|
XLNX
164
DELISTED
Xilinx Inc
XLNX
| $17.4M | 0.14% |
147,143
-15,455
| -10% | -$1.8M |
|
165
British American Tobacco
BTI
$132B
| $17M | 0.14% |
488,922
-39,583
| -7% | -$1.5M |
|
166
ExxonMobil
XOM
$651B
| $17M | 0.14% |
222,271
+46,651
| +27% | +$3.61M |
|
167
ScottsMiracle-Gro
SMG
$4.03B
| $16.9M | 0.14% |
172,044
+9,052
| +6% | +$805K |
|
168
Intuitive Surgical
ISRG
$121B
| $16.7M | 0.14% |
95,772
-2,586
| -3% | -$443K |
|
169
PPG Industries
PPG
$25.9B
| $16.7M | 0.14% |
143,434
+6,214
| +5% | +$708K |
|
170
Booz Allen Hamilton
BAH
$8.7B
| $16.7M | 0.14% |
252,585
-12,304
| -5% | -$756K |
|
171
iShares TIPS Bond ETF
TIP
$14.5B
| $16.5M | 0.13% |
142,659
+33,523
| +31% | +$3.81M |
|
172
iShares Core US Aggregate Bond ETF
AGG
$138B
| $16.3M | 0.13% |
146,159
+10,930
| +8% | +$1.2M |
|
173
Charter Communications
CHTR
$14.7B
| $16.3M | 0.13% |
41,182
+1,772
| +4% | +$664K |
|
174
ConocoPhillips
COP
$147B
| $16M | 0.13% |
262,494
-26,890
| -9% | -$1.67M |
|
175
Prudential
PUK
$36.5B
| $16M | 0.13% |
375,598
+12,947
| +4% | +$539K |
|
Similar funds
Natixis Advisors's Q2 2019 Portfolio in Review
As of Q2 2019, Natixis Advisors held 1,100 positions worth $12.2B, up 7.2% from $11.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Natixis Advisors's Q2 2019 filing shows 46 new, 577 increased, 433 reduced and 42 closed positions. Its largest new stake was Alcon: 306,725 shares worth $19M. The largest sale was Ecolab, an estimated $22.6M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Financials and Healthcare.
- Natixis Advisors's largest Q2 2019 buy was Alcon: 306,725 shares worth $19M.
- Natixis Advisors added most to Vanguard FTSE Developed Markets ETF in Q2 2019, an estimated $28.9M increase.
- Natixis Advisors's biggest Q2 2019 reduction was Ecolab, cutting an estimated $22.6M.
- Natixis Advisors fully exited Clorox in Q2 2019, selling an estimated $15.2M.
- Natixis Advisors's ten largest holdings make up 15% of its $12.2B portfolio in Q2 2019.
- Natixis Advisors opened 46 new positions and closed 42 in Q2 2019.
- Natixis Advisors's portfolio value rose 7.2% quarter-over-quarter to $12.2B.
Based on Natixis Advisors's 13F filing for Q2 2019, filed 12 Aug 2019.